Access Statistics for Marisa Miraldo

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Are You What You Eat? Experimental Evidence on Health Habits and Risk Preferences 0 1 3 218 0 4 8 434
Are you what you eat? Experimental evidence on risk preferences and health habits 0 0 1 129 1 1 3 135
Bandwagoning, free-riding and heterogeneity in influenza vaccine decisions: an online experiment 0 0 0 9 4 5 13 28
Collusion in regulated pluralistic markets 0 0 0 23 2 2 2 48
Doctor-patient differences in risk preferences, and their links to decision-making: a field experiment 0 0 0 28 0 1 2 90
Doctor–patient differences in risk and time preferences: a field experiment 0 0 0 38 0 2 4 56
Economies of scale and scope in the English hospital sector 0 0 2 112 0 0 4 268
Establishing a Fair Playing Field for Payment by Results 0 0 0 68 1 3 5 229
Hospital Financing and the Development and Adoption of New Technologies 0 0 0 83 0 1 2 290
Identification of Peer Effects using Panel Data 0 0 0 43 0 2 3 48
Identification of Peer Effects using Panel Data 0 0 1 12 2 4 10 30
In sickness but not in wealth: Field evidence on patients’ risk preferences in the financial and health domain 0 0 0 2 1 1 2 77
In sickness but not in wealth: field evidence on patients’ risk preferences in the financial and health domain 0 1 1 58 4 6 8 83
Inequities in cancer drug development in terms of unmet medical need 0 0 0 0 5 5 5 8
Inequities in cancer drug development in terms of unmet medical need 0 0 0 0 3 3 3 9
Inequities in cancer drug development in terms of unmet medical need 0 0 0 0 3 4 7 19
Innovation Diffusion and Physician Networks: Keyhole Surgery for Cancer in the English NHS 0 0 0 21 0 2 2 41
Innovation Diffusion and Physician Networks: Keyhole Surgery for Cancer in the English NHS 0 0 0 33 2 4 5 59
Optimal Contracts and Contractual Arrangements Within the Hospital: Bargaining vs. Take-it-or-leave-it Offers 0 0 0 71 0 0 2 240
Peer and network effects in medical innovation: the case of laparoscopic surgery in the English NHS 0 0 0 106 1 1 9 184
Physician altruism and moral hazard: (no) evidence from Finnish national prescriptions data 0 0 0 8 1 2 2 36
Price Adjustment in the Hospital Sector 0 0 0 79 2 3 4 293
Price regulation of pluralistic markets subject to provider collusion 0 0 0 32 2 2 2 229
Price regulation of pluralistic markets subject to provider collusion 0 0 0 24 0 0 1 87
Reference Pricing Versus Co-Payment in the Pharmaceutical Industry: Firm's Pricing Strategies 0 0 0 124 1 1 2 418
Reference Pricing Versus Co-Payment in the Pharmaceutical Industry: Price, Quality and Market Coverage 0 0 0 149 1 1 2 328
The costs of new organisational and financial freedom: The case of English NHS trusts 0 0 0 37 0 0 2 175
The determinants of attrition in drug development: a duration analysis 0 0 1 60 0 4 10 170
The incentive effects of payment by results 0 0 2 337 1 1 12 814
Total Working Papers 0 2 11 1,904 37 65 136 4,926

Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Are English treatment centres treating less complex patients? 0 0 0 19 1 1 2 86
Are You What You Eat? Healthy Behaviour and Risk Preferences 0 0 1 3 0 0 3 20
Bandwagoning, free‐riding and heterogeneity in influenza vaccine decisions: An online experiment 0 0 0 2 0 1 1 9
Broadening the lens: a commentary on Sheard and Cauana-Finkel's account of women's progress in UK academic health economics 0 0 0 0 1 1 1 1
Distribution of health-related social surplus in pharmaceuticals: an estimation of consumer and producer surplus in the management of high blood lipids and COPD 0 0 0 7 1 2 2 73
Doctor–patient differences in risk and time preferences: A field experiment 0 0 0 20 2 5 8 106
Does global drug innovation correspond to burden of disease? The neglected diseases in developed and developing countries 0 0 1 15 0 2 5 40
Effects of Reference Pricing in Pharmaceutical Markets 0 0 0 37 3 5 6 176
Erratum to: Distribution of health-related social surplus in pharmaceuticals: an estimation of consumer and producer surplus in the management of high blood lipids and COPD 0 0 0 1 2 2 2 10
Excess influenza hospital admissions and costs due to the 2009 H1N1 pandemic in England 0 0 0 4 1 1 4 38
Food environment and diabetes mellitus in South Asia: A geospatial analysis of health outcome data 0 0 0 0 1 1 1 1
Giving greater financial independence to hospitals—does it make a difference? The case of English NHS Trusts 0 0 0 64 1 2 8 179
Impact of extreme temperatures on emergency hospital admissions by age and socio-economic deprivation in England 0 0 0 2 1 1 2 11
Impacts of introducing and lifting nonpharmaceutical interventions on COVID-19 daily growth rate and compliance in the United States 0 0 0 0 1 4 6 10
In Sickness but Not in Wealth 0 0 0 0 0 1 1 3
Inequities in cancer drug development in terms of unmet medical need 0 0 0 1 0 1 1 6
Innovation Diffusion Among Coworkers: Evidence from Senior Doctors 1 2 2 2 5 14 14 14
Optimal Hospital Care Scheduling During the SARS-CoV-2 Pandemic 0 0 0 2 0 0 1 8
Physician altruism and moral hazard: (no) Evidence from Finnish national prescriptions data 0 0 0 8 3 4 7 64
Price adjustment in the hospital sector 0 0 0 23 0 3 4 132
Projected impact of the Portuguese sugar-sweetened beverage tax on obesity incidence across different age groups: A modelling study 0 0 0 5 1 3 3 33
Reference pricing and firms' pricing strategies 0 0 1 187 1 1 4 752
Should prospective payments be differentiated for public and private healthcare providers? 0 0 0 29 0 1 2 92
The Determinants of Cost-Effectiveness Potential: An Historical Perspective on Lipid-Lowering Therapies 0 0 0 2 0 0 0 30
The effects of hospitals' governance on optimal contracts: Bargaining vs. contracting 0 0 0 33 1 3 4 146
The impact of hospital price and quality transparency tools on healthcare spending: a systematic review 0 0 0 2 0 1 3 12
The impact of publicly subsidised health insurance on access, behavioural risk factors and disease management 0 0 0 3 1 1 2 28
The impact of the consumer and neighbourhood food environment on dietary intake and obesity-related outcomes: A systematic review of causal impact studies 0 0 1 4 1 3 7 29
The importance of surgeons and their peers in adoption and diffusion of innovation: An observational study of laparoscopic colectomy adoption and diffusion in England 0 0 0 4 0 2 2 14
The role of patient organisations in research and development: Evidence from rare diseases 0 0 0 0 1 1 2 3
Waiting time at health facilities and social class: Evidence from the Indian caste system 0 0 0 0 2 4 6 14
Total Journal Articles 1 2 6 479 31 71 114 2,140

Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Experimental Methods and Behavioral Insights in Health Economics: Estimating Risk and Time Preferences in Health 0 0 1 5 1 1 9 17
R&D Success in Pharmaceutical Markets: A Duration Model Approach 0 0 2 3 0 0 5 8
Total Chapters 0 0 3 8 1 1 14 25

logo

LogEc Home

Top Working Papers
Top Journal Articles
Top Books
Top Chapters
Top Software Items

Top Authors

Top Working Paper series and Journals

About LogEc

Authors with papers registered in the RePEc Author Service.

Register yourself as an author or register more papers in the RePEc Author Service.

Authors with no registered papers

RePEc
LogEc provides access and usage statistics for services based on the RePEc data set.

Örebro UniversityLogEc is hosted by the Örebro University School of Business.

Questions or comments? Please see our explanation of how the statistics are collected or e-mail

Statistics updated 2025-12-06